302
Participants
Start Date
January 31, 2011
Primary Completion Date
September 30, 2013
Study Completion Date
January 31, 2014
Blazer® Open-Irrigated Ablation Catheter
Blazer® Open-Irrigated Ablation Catheter
Control Catheter
Open-irrigated radiofrequency ablation catheters that have received FDA market approval for the treatment of type 1 atrial flutter
Strong Memorial Hospital of the University of Rochester, Rochester
Washington Hospital Center, Washington D.C.
Sentara Norfolk General Hospital, Norfolk
Moses H. Cone Memorial Hospital, Greensboro
Medical University of South Carolina, Charleston
Emory University Hospital, Atlanta
Georgia Health Sciences University, Augusta
Tallahassee Memorial Hospital, Tallahassee
West Coast Arrhythmia Center, Hudson
University of Alabama at Birmingham, Birmingham
Central Baptist Hospital, Lexington
Ohio State University Medical Center, Columbus
Ohio Health Research Institute, Columbus
ProMedica Toledo Hospital, Toledo
Cleveland Clinic Foundation, Cleveland
Henry Ford Hospital, Detroit
University of Kansas Hospital, Kansas City
Nebraska Heart Institute, Lincoln
Hall Garcia Cardiology, Houston
Texas Cardiac Arrhythmia Research, Austin
Colorado Springs Cardiologist, P.C., Colorado Springs
St. Jude Medical Center, Fullerton
Regional Cardiology Associates, Sacramento
Swedish Medical Center, Seattle
Brigham and Women's Hospital, Boston
Caritas St. Elizabeth's Medical Center, Boston
Lead Sponsor
Boston Scientific Corporation
INDUSTRY